Global Health Limited — Board Meeting, 07-08-2025: Outcome of Board Meeting

Global Health Limited (Medanta) has announced a board meeting where it approved strong financial results for the quarter ended June 30, 2025. Consolidated revenue climbed to ₹1,030.84 Cr, with profit after tax hitting ₹158.98 Cr, partly boosted by a ₹19.59 Cr reversal of interest liability.

The board proposed a final dividend of ₹0.50 per share for FY24-25, pending shareholder approval at the September 19, 2025 AGM. The record date is August 22, 2025.

Strategic moves include the approval of land acquisition in Guwahati for a new super speciality hospital, with a larger 3.5-acre substitute parcel now offered. Key leadership was affirmed with the re-appointment of Dr. Naresh Trehan as CMD, and Independent Directors Mr. Vikram Singh Mehta and Mr. Hari Shanker Bhartia.